AnalystsMazahir AlimohamedMazahir Alimohamed's Stock Forecasts
AnalystsMazahir Alimohamed
Sectors:
Industries:
Analyst Ranking
Bottom 23%
#4291 out of 5510 analysts
Average Return
-8.01%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good
Mazahir Alimohamed's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Quince Therapeutics IncQNCX | +31.64% | $22.00 | $28.96 | 2026-07-29 - 2026-09-10 | Buy |
Mazahir Alimohamed Analyst Color
Get additional color on Mazahir Alimohamed's coverage of popular stocks
Mazahir Alimohamed's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Quince Therapeutics IncQNCX | 1 | Buy | $82.00 | +183.15% | Initiates Coverage On | a month ago |
Connect Biopharma Holdings LtdCNTB | 1 | Buy | $8.00 | +288.35% | Initiates Coverage On | 2 months ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $51.00 | +18.88% | Initiates Coverage On | 2 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $22.00 | +298.55% | Assumes | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.